Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
-12.93%
↑ 37% above average
Average (9y)
-20.49%
Historical baseline
Range
High:11.84%
Low:-55.86%
CAGR
-0.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -12.93% | +76.9% |
| 2023 | -55.86% | -41.3% |
| 2022 | -39.55% | -1129.9% |
| 2021 | -3.22% | -127.2% |
| 2020 | 11.84% | +860.7% |
| 2019 | 1.23% | +104.5% |
| 2018 | -27.20% | +37.9% |
| 2017 | -43.81% | -99.5% |
| 2016 | -21.96% | -63.9% |
| 2015 | -13.39% | - |